Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The incorporation of 5-fluorouracil metabolites, specifically fluorouridine triphosphate (FUTP), into RNA during transcription. This process disrupts normal RNA function, particularly ribosomal RNA (rRNA), leading to impaired translation, stress response activation, and ultimately, cytotoxicity in cancer cells treated with 5-fluorouracil.
Incorporation of fluorouridine triphosphate (FUTP) into RNA in place of UTP, leading to dysfunctional RNA and impaired protein synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5-Fluorouracil Metabolite Incorporation into RNA (None).